CClinicalTrials.gg
CompletedNCT06670924Updated Nov 4, 2024

Suturing Techniques for Vesico-urethral Anastomosis

An interventional study of Running suture for vesico-urethral anastomosis in open radical prostatectomy and interrupted suture for vesico-urethral anastomosis in open radical prostatectomy in Prostate Cancer Surgery, sponsored by Kartal City Hospital. Completed at 1 site in Turkey. Open to male participants. Per ClinicalTrials.gov, last updated 2024-11-04.

Sponsored by Kartal City Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 8 months after the study started (first participant enrolled Feb 2022, registered Oct 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Sex
Male
01

Study summary

Radical prostatectomy (RP) is the most common curative treatment for prostate cancer (PCa).Vesicourethral anastomosis (VUA) is a crucial step and either a conventional interrupted (IS) or a running (RS) suture is employed during radical prostatectomy (RP). Certainly, both RS and IS have advantages and limitations. The metanalysis revealed that potential advantages for RS compared to IS, especially for short-term outcomes such as catheterization time, extravasation rate, and anastomotic suture time. There were no significant differences for long-term outcomes (continence, incidence of vesicourethral anastomotic stenosis). Generally, the exciting evidence suggests that CS should be preferred over IS. However, this should be followed only if it is technically feasible and appropriate regarding the surgical approach. Both techniques seem to be safe and appropriate for the VUA, and the technique should be chosen based on individual experience and preference.

The investigators hypothesized that RS and IS may have different effects on voiding function and flow rate, even if they do not cause an anastomotic stenosis requiring intervention. Furthermore, there is no existing literature that compares RS and IS in terms of voiding function.This article focuses on one year uroflowmetric voiding parameters, urinary function (UF), and UF related bother function, urinary continence recovery as well as other secondary outcomes, including surgical parameters, perioperative morbidity and oncological outcomes.

02

Conditions studied

  • Prostate Cancer Surgery

Browse trials for

Keywords

  • prostate cancer
  • vesicourethral anastomosis
  • voiding function
  • suture
03

In context

Prostatic Neoplasms

6,370 studies on the registry are indexed under Prostatic Neoplasms; 1,400 are open to participants now.

This study's enrollment of 70 is above the median of 58 across 4,822 interventional studies indexed under Prostatic Neoplasms.

Browse Prostatic Neoplasms studies →

Lead sponsor

Kartal City Hospital is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Clinical diagnosis of clinically localised (pT1-pT2) prostate cancer
  • must select the open radical prostatectomy procedure as a treatment option.

Exclusion criteria

Exclusion Criteria:

  • History of acute urinary retention
  • History of urethral stricture
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
70 participants (actual)

Study arms

  • Active comparator
    Running suture (RS)

    Running suture technique for vesico-urethral anastomosis in open radical prostatectomy

    Procedure: Running suture for vesico-urethral anastomosis in open radical prostatectomy

  • Active comparator
    Interrupted suture (IS)

    Interrupted suture technique for vesico-urethral anastomosis in open radical prostatectomy

    Procedure: interrupted suture for vesico-urethral anastomosis in open radical prostatectomy

Interventions

  • ProcedureRunning suture for vesico-urethral anastomosis in open radical prostatectomy

    The surgical technique of the RS followed the description of Van Velthovens, was applied with slight modifications. Two 3/0 absorbable monofilament (polydioxanone) sutures were used. The first needle is started from bladder neck at 3 o'clock, and terminated in the urethra at 9 o'clock. After completion of the posterior anastomosis, a transurethral catheter is placed. The second sutures' needle is passed from the bladder at 9 o'clock and ended in the urethra at 3 o'clock. The bladder neck and urethra are merged by gentle traction of the anterior and posterior sutures at 3 and 9 o'clock.

  • Procedureinterrupted suture for vesico-urethral anastomosis in open radical prostatectomy

    The technique described by Walsh for interrupted anastomotic suturing was applied with minor modifications. Six 3/0 absorbable monofilament (polydioxanone) sutures were placed at 1, 3, 5, 7, 9 and 11 o'clock to accomplish the vesicourethral anastomosis.

06

What researchers measure

Primary outcomes

  1. Maximum flow rate (MFR)

    Uroflowmetry is a noninvasive test that measures the rate of urine flow over time. Uroflowmetry involves a well-hydrated patient voiding into a uroflowmeter, which in turn generates a "flow curve." The flow curve enables the measurement of the MFR .A value of 15ml/sec or below is deemed to be outside the normal range.

    Time frame: preoperative and 1,3,6,12 months visits after surgery.

  2. Post-voiding residuel volume (PVR)

    PVR is defined as the residual urine volume in the bladder following voiding, as calculated by ultrasound imaging. A volume of 150 cc or above is regarded as pathological.

    Time frame: preoperative and 1,3,6,12 months visits after surgery.

  3. Urinary function(UF)

    Urinary function(UF) and urinary function-related bother: UF measured by the International Prostate Symptom Score \[IPSS\]) The IPSS is based on the answers to seven questions concerning urinary symptoms. Each question is assigned points from 0 to 5 indicating increasing severity of the particular symptom. The total score can therefore range from 0 to 35 . UF-related bother measured by the IPSS quality of life question with a response from 0 to 6.

    Time frame: preoperative and 1,3,6,12 months visits after surgery.

  4. Continence recovery

    Urinary continence recovery defined as patient-reported use of zero pad or one security pad per day.

    Time frame: preoperative and 1,3,6,12 months visits after surgery.

Secondary outcomes

  1. Surgical parameters

    Duration of vesico-urethral anastomosis time

    Time frame: During the operation

  2. Anastomotic extravasation

    Presence of anastomotic extravasation on first cystogram

    Time frame: Postoperative day 5.

  3. Perioperative complications

    Clavien-Dindo scoring system

    Time frame: Through study completion, an average of 1 year

07

Study locations

1 site
  • University of Health Sciences Kartal Dr. Lütfi Kırdar City Hospital
    Istanbul, 34865, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06670924
Lead sponsor
Kartal City Hospital
Responsible party
Utku Can (Assistant professor of urology, Kartal City Hospital) — Principal investigator
First posted
Nov 1, 2024
Start date
Feb 7, 2022
Primary completion
Aug 1, 2023
Completion
Aug 16, 2024
Last update
Nov 4, 2024

Study contacts

Utku Can
principal investigator · Kartal Dr Lutfi Kirdar City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion